Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

Cancer Research - United States
doi 10.1158/0008-5472.can-07-6102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Development and in Vitro Characterization of a Gemcitabine-Loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma

Anticancer Research
MedicineCancer ResearchOncology
2017English

HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2006English

Targeted Delivery of Antisense Oligonucleotides to Pancreatic Β-Cells

Science advances
Multidisciplinary
2018English

Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach

PLoS ONE
Multidisciplinary
2012English

Cetuximab Plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Metastatic Pancreatic Cancer: A Multicentre Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

A Case Report of Gemcitabine-Induced Steatohepatitis Associated With Adjuvant Monotherapy for Pancreatic Adenocarcinoma

The Medicine Forum
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy